Dalfampridine and Gait in Spinocerebellar Ataxias

Summary

Investigators expect there will be improvement in walking speed and steadiness after taking Dalfampridine, thereby improving activities of daily living and enhancing social and occupational functions for patients with spinocerebellar ataxia.

Timeline

Start

2013-02

Primary completion

2013-12

Completion

2013-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Dalfampridine vs Placebo; p >0.05; t-test, 2 sided NCT01811706 ↗

Drugs

Indications